NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 07/02/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization591.3 mln
Float17.56 mln
Earnings Date07/31/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-2.64
Likely reliable
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.01
Debt-free
ROE
-6.67
Negative
Dividend Yield
0.00%
No dividend
Business Description
Fulgent Genetics is a California-based healthcare company that offers a broad range of genetic and diagnostic testing services to patients, physicians, hospitals, and insurers across the United States and beyond. Their testing capabilities cover areas such as cancer screening, reproductive health, and tissue pathology, supported by proprietary software that helps identify meaningful health markers in a person's DNA. The company also develops cancer treatments using a specialized drug delivery platform designed to make therapies more effective and better tolerated by patients.
